Ser Educacional (SEER3) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
20 Aug, 2026Company profile and market position
One of Brazil's largest higher education groups, with a student base of 334,000 in 2025 and a national omnichannel presence through 61 campuses and 689 digital learning centers.
Strong regional brands lead in key markets such as Pará, Amazonas, Pernambuco, and São Paulo, offering both on-campus and distance learning programs.
Health courses represent a significant portion of the student base, with medical, dentistry, and veterinary programs in high demand.
Track record of organic growth and strategic M&A, expanding both student base and course offerings.
Mission focuses on innovative, inclusive education and social transformation.
Strategic pillars and growth initiatives
Six strategic pillars for 2026: organic growth, medical course expansion, quality and differentiation, shareholder remuneration, financial deleveraging, and operational efficiency.
Investment in technology, digital content, and hybrid learning models to enhance student experience and academic quality.
Expansion of medical courses, with 1,001 annual seats by 2025, and participation in public calls for new vacancies.
Focus on high-demand courses (health, law), process automation, and new business development in continuing education and fintech.
Consistent dividend policy with a 30% payout on a semi-annual basis.
Financial performance and operational efficiency
Net revenue reached R$2.29 billion in 2025, with adjusted EBITDA of R$592 million and a margin of 26%.
Net income improved to R$214 million in 2025, with a net margin of 9.2%.
Significant increase in operational efficiency: on-campus students per unit rose to 3,198 in 2024.
Net debt/EBITDA reduced to 0.75x by 2Q26, reflecting strong deleveraging.
Cash generation and EBITDA conversion rates improved, supporting financial sustainability.
Latest events from Ser Educacional
- Net income up 30.7%, net debt/EBITDA at 0.75x, and dividends more than tripled.SEER3
Q2 2026 - Net income up 74%, net debt/EBITDA at 0.75x, with strong on-campus and medical program growth.SEER3
Q1 2026 - Net income of R$214.4 million, margin gains, and lower leverage reflect robust growth.SEER3
Q4 2025 - Net revenue up 8.4%, adjusted net income up 24.5%, and net debt down 21.9%.SEER3
Q3 2025 - Net income jumped 66.4% and adjusted EBITDA rose 25% on strong hybrid and medical growth.SEER3
Q2 2025 - Q3 2024 saw double-digit revenue and EBITDA growth, margin expansion, and a return to profit.SEER3
Q3 2024 - Net revenue and margins grew, leverage fell, and regulatory wins expanded medical course seats.SEER3
Q2 2024 - Record cash generation and EBITDA growth driven by hybrid and medical education.SEER3
Q1 2025 - EBITDA and revenue rose, leverage declined, and dividends resume amid medical course expansion.SEER3
Q4 2024